Abortion, Induced
0
Pipeline Programs
3
Companies
3
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
3 companies ranked by most advanced pipeline stage
UNION therapeuticsDenmark - Hellerup
1 programEstradiol-Loaded Silicone Rubber Intrauterine Stent SystemN/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
UNION therapeuticsEstradiol-Loaded Silicone Rubber Intrauterine Stent System
MedicemDilapan-S
Angeles TherapeuticsDigoxin
Clinical Trials (3)
Total enrollment: 699 patients across 3 trials
To Study the Safety and Efficacy of A Novel Intrauterine Estrogen-Releasing System in Induced Abortion
Start: Mar 2026Est. completion: Aug 2026200 patients
N/ANot Yet Recruiting
Dilapan-S / Dilasoft E-Registry in Induced Abortion
Start: Mar 2015Est. completion: Dec 2016439 patients
N/ACompleted
Transvaginal Versus Transabdominal Digoxin Prior to Second-trimester Abortion
Start: Oct 2012Est. completion: Oct 201460 patients
N/ACompleted
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
3 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.